Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Nutra Pharma Corp. NPHC
(Total Views: 819)
Posted On: 01/25/2018 1:17:37 PM
Post# of 102
Posted By: spss2215
Insider Financial article further says

Quote:
NPHC intends to target this opportunity with Nyloxin, an OTC pain reliever for the treatment of moderate to severe chronic pain. It is formulated to treat back pain, neck pain, headaches, joint pain, migraines besides other types of pain.

We checked out the information about this product, and believe that the Nyloxin’s business strategy is smart. Nyloxin is intended for people without healthcare insurance, which is not a small number of individuals (42 million). Also, it is non-opiate and non-narcotic. Thus doctors should not be afraid of opiate side effects. The product targets those patients who cannot be treated with other products in the market.














(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site